MLchartDataset catalogue

Amcenestrant

Term · Oncology and biomedicine · MLC-T-ONC-010016

An orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, SERD SAR439859 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.

Table 1. Record
IdentifierMLC-T-ONC-010016
FieldOncology and biomedicine
Synonymsselective estrogen receptor downregulator SAR439859; selective estrogen receptor degrader SAR439859; SERD SAR439859
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-010016",
  "term": "Amcenestrant",
  "field": "Oncology and biomedicine",
  "definition": "An orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, SERD SAR439859 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.",
  "synonyms": [
    "selective estrogen receptor downregulator SAR439859",
    "selective estrogen receptor degrader SAR439859",
    "SERD SAR439859"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/amcenestrant/"
}

Record 943 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.